Clinicians will learn how to improve the results of treatment for alcohol use disorder and opioid use disorder using a combination of evidence-based pharmacotherapy and cognitive behavioral counseling.<\/p>\n
Psychiatry Grand Rounds: The\u00a0learner objectives<\/u><\/strong>\u00a0for this activity are to improve diagnostic skills, increase knowledge of all psychiatric disorders, and discuss recent advances in all areas of psychiatry, psychopharmacology, psychotherapy, and evaluative techniques.<\/p>\n The\u00a0intended audience<\/u><\/strong>\u00a0for this activity includes psychiatrists and psychologists.\u00a0 Other health care professionals, including physicians from other disciplines, residents, medical students, nurses, therapists, and social workers may also participate.<\/p>\n The Cooper Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The Cooper Health System takes responsibility for the content, quality, and scientific integrity of this CME activity.<\/p>\n The Cooper Health System designates this live activity for a maximum of\u00a01.5\u00a0AMA PRA Category 1 CreditsTM<\/sup>\u00a0<\/em>per session.\u00a0<\/strong>Physicians should claim only the credit commensurate with the extent of their participation in the activity.<\/p>\n Successful completion of one hour of a CME course recognized by the American Medical Association, the American Osteopathic Association, or the American Podiatric Medical Association is equal to one hour of continuing education for New Jersey nursing license renewal (New Jersey Board of Nursing 13:37-5.3).<\/p>\n All faculty participating in CME activities sponsored by The Cooper Health System are expected to disclose to the audience any real or apparent conflict of interest related to the content of their presentation. Full Disclosure Statements will remain on file in the Department of Continuing Medical Education.<\/p>\n
\nFocus on the Opioid Receptor in the Treatment of Alcoholism and Opioid Use Disorder
\nSpeaker: Charles O\u2019Brien, MD
\nEmeritus Professor, University of Pennsylvania
\nFounding Director, Center for Studies of Addiction
\nTuesday, August 28, 2018
\n<\/strong>11 a.m. to 12:30 p.m.
\n<\/strong>Dean\u2019s Conference Room
\n<\/strong>E&R Building
\n<\/strong>Camden<\/p>\n